HedgeChatter

  • Home /
  • Tag Archives

MNK

Mallinckrodt Receives Patent from U.S. Patent and Trademark Office

[Business Wire] – Mallinckrodt today announced that it was granted a patent from the United States Patent and Trademark Office which contains composition claims directed to unique design, formulation, pharmacokinetic, and release characteristics of XARTE moreView todays social media effects on MNKView the latest stocks trending across Twitter. Click to view dashboardSee who Mallinckrodt is hiring next, click here to […]

February 25, 2014 Bystocknews , Comments Off on Mallinckrodt Receives Patent from U.S. Patent and Trademark Office read more

Can the Rally in Mallinckrodt (MNK) Shares Continue?

moreView todays social media effects on MNKView the latest stocks trending across Twitter. Click to view dashboardSee who Mallinckrodt is hiring next, click here to view […]

February 20, 2014 Bystocknews , Comments Off on Can the Rally in Mallinckrodt (MNK) Shares Continue? read more

CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

[PR Newswire] – WILMINGTON, Del., Feb. 14, 2014 /PRNewswire/ — Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Cadence Pharmaceuticals, Inc. (Cadence … moreView todays social media effects on MNKView the latest stocks trending across Twitter. Click to view dashboardSee who Mallinckrodt is hiring next, click here to view […]

February 14, 2014 Bystocknews , Comments Off on CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout read more

MALLINCKRODT PLC Financials

moreView todays social media effects on MNKView the latest stocks trending across Twitter. Click to view dashboardSee who Mallinckrodt is hiring next, click here to view […]

February 13, 2014 Bystocknews , Comments Off on MALLINCKRODT PLC Financials read more

Acquisition of Cadence Pharmaceuticals, Inc. by Mallinckrodt plc May Not Be in Shareholders’ Best Interests

[PR Newswire] – SAN DIEGO, Feb. 11, 2014 /PRNewswire/ — Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Cadence Pharmaceuticals, Inc. (CADX) by Mallinckrodt plc (MNK). On February 11, 2014, the two compan moreView todays social media effects on MNKView the latest stocks trending across Twitter. Click to view dashboardSee who Mallinckrodt is hiring next, […]

February 11, 2014 Bystocknews , Comments Off on Acquisition of Cadence Pharmaceuticals, Inc. by Mallinckrodt plc May Not Be in Shareholders’ Best Interests read more